| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |